With the humanization of pets, Biorigin finds that owners seek pet food with similar appeal to the food they seek for themselves. Produced from yeasts and derivatives, the company's portfolio includes natural solutions which have both functional and sensory properties. Biorigin's key product within this segment is the MacroGard, which will be the theme of the lecture given by professor Maria de Godoy of the University of Illinois.
“MacroGard is a smart immunomodulator that acts on the natural defenses, balancing their action and contributing to the endurance, health and well-being of pets. Studies conducted with MacroGard have shown positive effects in dogs with different conditions, such as atopic dermatitis, osteoarthritis and obesity. We invite the audience to attend the lecture and learn more about beta-glucans," complemented Carlos Alberto de Oliveira, Biorigin’s technical manager of the pet segment.
Biorigin's portfolio also includes solutions that “are interesting tools for food manufacturers to differentiate and segment the products according to specific needs, age groups, breed, etc. We have high-protein solutions that improve the attractiveness of the food, which promote the gut and the maintenance of natural defenses. They also are 100% natural, clean label, GMO Free, GMP+, 100% safe, since it guarantees the traceability of the entire production process from the raw material, and they are also sustainable," added Oliveira.
While cat trends continue, the pandemic has added to overall slow-growth treatment of the cat food market.
Premiumization and humanization, as well as automation, fueled continued operation growth in spite of the COVID-19 pandemic.